UT Health San Antonio study reveals how the liver’s internal clock may influence metabolism
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2026 14:15 ET (31-Oct-2026 18:15 GMT/UTC)
What if one of the keys to a healthier metabolism is understanding how and when the liver communicates with the rest of the body?
Researchers at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have uncovered how the liver’s internal clock coordinates the release of proteins that help regulate metabolism.
New research finds that men who consume higher amounts of ultra-processed foods (UPFs) have significantly greater risks of prostate cancer. Analyzing nationally representative data from 17,024 U.S. men, researchers found a 29% higher risk among those in the three highest UPF-consumption groups and a 30% higher risk among those in the two highest groups. After adjusting for key factors, elevated risk remained significant, ranging from 24% to 31%.
A Case Western Reserve University–led research team is developing a noninvasive oral cancer test to help clinicians decide—chairside and within minutes— whether a suspicious lesion in the mouth needs a biopsy.
CAMBRIDGE, Mass., Aug 12 — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. Notably, this marks the company's 9th PCC nomination announced since 2026, showcasing the enhanced efficiency and scalability that generative AI brings to early-stage drug discovery.
A new commentary published in a special issue of the American Journal of Public Health argues that the current application process for public assistance programs such as SNAP and Medicaid creates “a lose-lose scenario," as eligible applicants often abandon the time-consuming applications out of frustration and miss out on opportunities to improve their health, which defeats the purpose of these services.
Ribosomes, the protein factories of our cells, have difficulties building large proteins residing in cellular membranes, a new study finds / publication in The EMBO Journal
People with both atrial fibrillation and Alzheimer’s disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline. This is shown by a study from Karolinska Institutet published in the European Heart Journal.
A study in the Chinese Medical Journal reveals that the mitochondrial protein RTN4IP1 drives triple-negative breast cancer metastasis by interacting with AK4, depleting NAD⁺, and disrupting glycolysis and oxidative phosphorylation. RTN4IP1 knockdown suppresses metastatic outgrowth without affecting initial seeding. The findings identify RTN4IP1 and its interaction with AK4 as promising therapeutic targets for this aggressive cancer.